
Pharmstandard
Europe, Moscow City, Russian Federation, Moscow
Description
Pharmstandard is a pharmaceutical company that develops and manufactures modern pharmaceutical products.
Investor Profile
Pharmstandard has backed more than 13 startups, with 0 new investments in the last 12 months alone. The firm has led 8 rounds, about 62% of its total and boasts 7 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Private Equity, Series D rounds (top funding stages).
- Majority of deals are located in United States, Canada, Australia.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
Stage Focus
- Series B (38%)
- Private Equity (8%)
- Series D (8%)
- Debt Financing (8%)
- Series C (8%)
- Series E (8%)
- Post Ipo Equity (8%)
- Seed (8%)
- Convertible Note (8%)
Country Focus
- United States (77%)
- Canada (8%)
- Australia (8%)
- Russian Federation (8%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Medical
- Therapeutics
- Eyewear
- Genetics
- Medical Device
- Service Industry
- Wellness
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Pharmstandard frequently co-invest with?
What are some of recent deals done by Pharmstandard?
Find More Investors Like Pharmstandard
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides







